Pfizer's oxycodone/naltrexone extended-release capsules for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It has been formulated with the intent to provide abuse-deterrent properties.
Read MoreJUN 8 AADPAC-DSRM
Pfizer's oxycodone/naltrexone extended-release capsules for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It has been formulated with the intent to provide abuse-deterrent properties.
Read MoreJUN 8 AADPAC-DSRM-BA
Pfizer's oxycodone/naltrexone extended-release capsules for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. It has been formulated with the intent to provide abuse-deterrent properties.
Read MoreOCT 16 PDAC-DSRM
Serious neurologic AE's with Pfizer's Chantix
Read More